|
|
|
Insider
Information: |
Eshelman Fredric N |
Relationship: |
10% Owner |
City: |
Wilmington |
State: |
NC |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
6 |
|
Direct
Shares |
8,151,654 |
|
Indirect Shares
|
3,933,809 |
|
|
Direct
Value |
$92,582,699 |
|
|
Indirect Value
|
$12,515,195 |
|
|
Total
Shares |
12,085,463 |
|
|
Total
Value |
$105,097,894 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
7
|
3
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
7
|
3
|
|
|
|
Gain/Loss Ratio : |
-7.0
|
-3.0
|
Percentage
Gain/Loss : |
-45.7%
|
-43.6%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Pharmaceutical Product Developme... |
PPDI |
Executive Chairman, Di... |
2011-12-05 |
0 |
2011-12-05 |
0 |
Premium* |
|
Furiex Pharmaceuticals, Inc. |
FURX |
Director, 10% Owner |
2014-07-02 |
0 |
2014-07-02 |
0 |
Premium* |
|
Bausch Health Companies Inc |
BHC |
Director |
2017-05-05 |
38,298 |
2016-03-11 |
0 |
Premium* |
|
G1 Therapeutics Inc |
GTHX |
Director, 10% Owner |
2017-11-13 |
250,000 |
2017-11-13 |
3,439,151 |
Premium* |
|
Eyenovia Inc |
EYEN |
Director |
2020-09-11 |
1,292,787 |
2020-09-11 |
319,085 |
Premium* |
|
Liquidia Technologies Inc |
LQDA |
10% Owner |
2020-11-25 |
6,570,569 |
2020-11-25 |
175,573 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
148 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 3 of 6
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
LQDA |
Liquidia Technologies Inc |
10% Owner |
|
2020-11-25 |
4 |
S |
$3.13 |
$54,349 |
D/D |
(17,364) |
6,570,569 |
0 |
% |
|
PPDI |
Pharmaceutical Product De... |
CEO |
|
2005-07-22 |
4 |
S |
$59.02 |
$1,076,796 |
D/D |
(17,947) |
4,962,263 |
|
- |
|
PPDI |
Pharmaceutical Product De... |
CEO |
|
2007-05-01 |
4 |
S |
$34.63 |
$663,142 |
D/D |
(19,000) |
8,831,627 |
0 |
- |
|
FURX |
Furiex Pharmaceuticals, I... |
Director |
|
2012-05-23 |
4 |
B |
$17.73 |
$354,600 |
D/D |
20,000 |
2,270,435 |
3.92 |
- |
|
FURX |
Furiex Pharmaceuticals, I... |
Director |
|
2011-12-14 |
4 |
B |
$16.70 |
$334,935 |
D/D |
20,056 |
1,960,291 |
3.92 |
- |
|
PPDI |
Pharmaceutical Product De... |
CEO |
|
2007-06-01 |
4 |
S |
$36.91 |
$789,374 |
D/D |
(21,341) |
8,600,827 |
0 |
- |
|
PPDI |
Pharmaceutical Product De... |
CEO |
|
2007-07-16 |
4 |
S |
$38.37 |
$824,675 |
D/D |
(21,400) |
8,396,126 |
0 |
- |
|
PPDI |
Pharmaceutical Product De... |
Chief Executive Officer |
|
2004-07-07 |
4 |
GD |
$0.00 |
$0 |
D/D |
22,000 |
4,964,263 |
|
- |
|
PPDI |
Pharmaceutical Product De... |
Chief Executive Officer |
|
2004-07-16 |
4/A |
GD |
$0.00 |
$0 |
D/D |
22,000 |
4,964,263 |
|
- |
|
FURX |
Furiex Pharmaceuticals, I... |
Director |
|
2012-03-12 |
4 |
B |
$22.69 |
$507,144 |
D/D |
22,351 |
2,060,626 |
3.92 |
- |
|
FURX |
Furiex Pharmaceuticals, I... |
Director |
|
2012-03-13 |
4 |
B |
$23.45 |
$529,829 |
D/D |
22,594 |
2,158,220 |
3.92 |
- |
|
FURX |
Furiex Pharmaceuticals, I... |
Director |
|
2012-03-14 |
4 |
B |
$23.75 |
$539,434 |
D/D |
22,713 |
2,180,933 |
3.92 |
- |
|
FURX |
Furiex Pharmaceuticals, I... |
Director |
|
2011-11-18 |
4 |
B |
$15.87 |
$374,929 |
D/D |
23,625 |
1,647,734 |
3.92 |
- |
|
PPDI |
Pharmaceutical Product De... |
CEO |
|
2007-04-16 |
4 |
S |
$34.05 |
$813,495 |
D/D |
(23,800) |
8,910,160 |
0 |
- |
|
PPDI |
Pharmaceutical Product De... |
CEO |
|
2007-04-16 |
4 |
S |
$34.69 |
$860,186 |
D/D |
(24,733) |
8,850,627 |
0 |
- |
|
PPDI |
Pharmaceutical Product De... |
CEO |
|
2005-05-18 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
4,982,263 |
|
- |
|
FURX |
Furiex Pharmaceuticals, I... |
Director |
|
2011-12-01 |
4 |
B |
$17.60 |
$440,458 |
D/D |
25,026 |
1,707,308 |
3.92 |
- |
|
PPDI |
Pharmaceutical Product De... |
CEO |
|
2007-02-20 |
4 |
S |
$33.49 |
$842,609 |
D/D |
(25,133) |
9,267,293 |
0 |
- |
|
BHC |
Bausch Health Companies I... |
Director |
|
2017-05-05 |
4 |
A |
$0.00 |
$0 |
D/D |
25,406 |
38,298 |
0 |
- |
|
FURX |
Furiex Pharmaceuticals, I... |
Director |
|
2012-05-24 |
4 |
B |
$17.99 |
$485,730 |
D/D |
27,000 |
2,297,435 |
3.92 |
- |
|
FURX |
Furiex Pharmaceuticals, I... |
Director |
|
2011-12-02 |
4 |
B |
$17.50 |
$483,910 |
D/D |
27,652 |
1,734,960 |
3.92 |
- |
|
PPDI |
Pharmaceutical Product De... |
CEO |
|
2007-06-18 |
4 |
S |
$36.86 |
$1,028,407 |
D/D |
(27,852) |
8,517,293 |
0 |
- |
|
LQDA |
Liquidia Technologies Inc |
10% Owner |
|
2020-03-31 |
4 |
B |
$4.87 |
$146,112 |
I/I |
30,000 |
44,100 |
1.5 |
% |
|
LQDA |
Liquidia Technologies Inc |
10% Owner |
|
2020-11-19 |
4 |
D |
$3.35 |
$100,500 |
D/D |
(30,000) |
7,004,744 |
0 |
- |
|
PPDI |
Pharmaceutical Product De... |
CEO |
|
2008-05-20 |
4 |
S |
$42.52 |
$1,310,091 |
D/D |
(30,780) |
8,083,846 |
0 |
- |
|
148 Records found
|
|
Page 3 of 6 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|